GEORGE CHOLANKERIL

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address2450 HOLCOMBE
Houston, TX 77021
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Tarlow B, Gubatan J, Khan MA, Cholankeril G. Are Proton Pump Inhibitors Contributing to SARS-COV-2 Infection? Am J Gastroenterol. 2020 Sep 11. PMID: 32925197.
      Citations:    Fields:    
    2. Kim D, Vazquez-Montesino LM, Escober JA, Fernandes CT, Cholankeril G, Loomba R, Harrison SA, Younossi ZM, Ahmed A. Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality. Am J Gastroenterol. 2020 09; 115(9):1496-1504. PMID: 32496342.
      Citations:    Fields:    Translation:Humans
    3. Kim D, Cholankeril G, Loomba R, Ahmed A. Prevalence of Fatty Liver Disease and Fibrosis Detected by FibroScan in Adults in the United States, 2017-2018. Clin Gastroenterol Hepatol. 2020 Aug 12. PMID: 32801011.
      Citations:    Fields:    
    4. Kim D, Murag S, Cholankeril G, Cheung A, Harrison SA, Younossi ZM, Ahmed A. Physical Activity, Measured Objectively, is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2020 Jul 16. PMID: 32683103.
      Citations:    Fields:    
    5. Cholankeril G, Podboy A, Alshuwaykh OS, Kim D, Kanwal F, Esquivel CO, Ahmed A. Early Impact of COVID-19 on Solid Organ Transplantation in the United States. Transplantation. 2020 Jul 14. PMID: 32675741.
      Citations:    Fields:    
    6. Cholankeril G, Podboy A, Aivaliotis VI, Pham EA, Spencer SP, Kim D, Ahmed A. Association of Digestive Symptoms and Hospitalization in Patients With SARS-CoV-2 Infection. Am J Gastroenterol. 2020 07; 115(7):1129-1132. PMID: 32618665.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    7. Podboy A, Cholankeril G, Cianfichi L, Guzman E, Ahmed A, Banerjee S. Implementation and Impact of Universal Preprocedure Testing of Patients for COVID-19 Before Endoscopy. Gastroenterology. 2020 Jun 17. PMID: 32562723.
      Citations:    Fields:    
    8. Adejumo AC, Akhtar DH, Dennis BB, Cholankeril G, Alayo Q, Ogundipe OA, Kim D, Ahmed A. Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA. Dig Dis Sci. 2020 Jun 13. PMID: 32535779.
      Citations:    Fields:    
    9. Kim D, Konyn P, Cholankeril G, Wong RJ, Younossi ZM, Ahmed A. Decline in Annual Mortality of Hepatitis C Virus-Related Hepatocellular Carcinoma in the United States, From 2009 to 2018. Gastroenterology. 2020 May 08. PMID: 32389664.
      Citations:    Fields:    
    10. Cholankeril G, Podboy A, Aivaliotas V, Pham EA, Tarlow B, Spencer S, Kim D, Hsing A, Ahmed A. Association of Digestive Symptoms and Hospitalization in Patients with SARS-CoV-2 Infection. medRxiv. 2020 Apr 28. PMID: 32511634.
      Citations:    
    11. Cholankeril G, Podboy A, Aivaliotis VI, Tarlow B, Pham EA, Spencer SP, Kim D, Hsing A, Ahmed A. High Prevalence of Concurrent Gastrointestinal Manifestations in Patients With Severe Acute Respiratory Syndrome Coronavirus 2: Early Experience From California. Gastroenterology. 2020 08; 159(2):775-777. PMID: 32283101.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    12. Marella HK, Reddy YK, Jiang Y, Ganguli S, Podila PSB, Snell PD, Kovalic AJ, Cholankeril G, Singal AK, Nair S, Maliakkal B, Satapathy SK. Accuracy of Noninvasive Fibrosis Scoring Systems in African American and White Patients With Nonalcoholic Fatty Liver Disease. Clin Transl Gastroenterol. 2020 Apr; 11(4):e00165. PMID: 32352687.
      Citations:    Fields:    
    13. Yoo ER, Cholankeril G, Ahmed A. Treating Alcohol Use Disorder in Chronic Liver Disease. Clin Liver Dis (Hoboken). 2020 Feb; 15(2):77-80. PMID: 32226621.
      Citations:    
    14. Kim D, Yoo ER, Li AA, Tighe SP, Cholankeril G, Ahmed A. Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014. Dig Dis Sci. 2020 Mar 02. PMID: 32124196.
      Citations:    Fields:    
    15. Dennis BB, Akhtar D, Cholankeril G, Kim D, Sanger N, Hillmer A, Chawar C, D'Elia A, Panesar B, Worster A, Marsh DC, Thabane L, Samaan Z, Ahmed A. The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study. Drug Alcohol Depend. 2020 04 01; 209:107917. PMID: 32088589.
      Citations:    Fields:    
    16. Kim D, Vazquez-Montesino LM, Li AA, Cholankeril G, Ahmed A. Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease. Hepatology. 2020 Feb 03. PMID: 32012316.
      Citations: 2     Fields:    
    17. Yoo ER, Kim D, Vazquez-Montesino LM, Escober JA, Li AA, Tighe SP, Fernandes CT, Cholankeril G, Ahmed A. Diet quality and its association with nonalcoholic fatty liver disease and all-cause and cause-specific mortality. Liver Int. 2020 04; 40(4):815-824. PMID: 31910319.
      Citations:    Fields:    
    18. Murag S, Dennis BB, Kim D, Ahmed A, Cholankeril G. Recent advances in liver transplantation with HCV seropositive donors. F1000Res. 2019; 8. PMID: 31942236.
      Citations:    Fields:    Translation:HumansCells
    19. Cholankeril G, Dennis BB, Kim D, Ahmed A. Regional Trends in Mortality from Alcohol-Induced Causes in the United States, 2000-2017. J Gen Intern Med. 2020 Aug; 35(8):2495-2498. PMID: 31792862.
      Citations:    Fields:    
    20. Kovalic AJ, Cholankeril G, Satapathy SK. Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations. Transl Gastroenterol Hepatol. 2019; 4:65. PMID: 31620647.
      Citations:    
    21. Adejumo AC, Kim D, Iqbal U, Yoo ER, Boursiquot BC, Cholankeril G, Wong RJ, Kwo PY, Ahmed A. Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease. J Palliat Med. 2020 01; 23(1):97-106. PMID: 31397615.
      Citations: 1     Fields:    
    22. Adejumo AC, Cholankeril G, Iqbal U, Yoo ER, Boursiquot BC, Concepcion WC, Kim D, Ahmed A. Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study. Dig Dis Sci. 2020 04; 65(4):990-1002. PMID: 31372912.
      Citations:    Fields:    Translation:Humans
    23. Kim D, Yoo ER, Li AA, Tighe SP, Cholankeril G, Harrison SA, Ahmed A. Depression is associated with non-alcoholic fatty liver disease among adults in the United States. Aliment Pharmacol Ther. 2019 09; 50(5):590-598. PMID: 31328300.
      Citations: 1     Fields:    Translation:Humans
    24. Kim D, Adejumo AC, Yoo ER, Iqbal U, Li AA, Pham EA, Cholankeril G, Glenn JS, Ahmed A. Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017. Gastroenterology. 2019 10; 157(4):1055-1066.e11. PMID: 31251928.
      Citations: 2     Fields:    Translation:Humans
    25. Kim D, Cholankeril G, Kim SH, Abbasi F, Knowles JW, Ahmed A. Increasing Mortality Among Patients With Diabetes and Chronic Liver Disease From 2007 to 2017. Clin Gastroenterol Hepatol. 2020 Apr; 18(4):992-994. PMID: 31220638.
      Citations:    Fields:    
    26. Cholankeril G, Li AA, Dennis BB, Gadiparthi C, Kim D, Toll AE, Maliakkal BJ, Satapathy SK, Nair S, Ahmed A. Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation. Sci Rep. 2019 06 05; 9(1):8312. PMID: 31165776.
      Citations: 1     Fields:    
    27. Kim D, Cholankeril G, Li AA, Kim W, Tighe SP, Hameed B, Kwo PY, Harrison SA, Younossi ZM, Ahmed A. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014. Liver Int. 2019 09; 39(9):1661-1671. PMID: 31081997.
      Citations: 2     Fields:    Translation:Humans
    28. Gadiparthi C, Yoo ER, Are VS, Charilaou P, Kim D, Cholankeril G, Pitchumoni C, Ahmed A. Hepatocellular carcinoma is leading in cancer-related disease burden among hospitalized baby boomers. Ann Hepatol. 2019 Sep - Oct; 18(5):679-684. PMID: 31164267.
      Citations:    Fields:    Translation:Humans
    29. Dibba P, Li AA, Cholankeril G, Ali Khan M, Kim D, Ahmed A. Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary. Nutr Metab Insights. 2019; 12:1178638819847480. PMID: 31308686.
      Citations:    
    30. Kim D, Li AA, Cholankeril G, Kim SH, Ingelsson E, Knowles JW, Harrington RA, Ahmed A. Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017. Diabetologia. 2019 07; 62(7):1185-1194. PMID: 31011776.
      Citations:    Fields:    Translation:Humans
    31. Kim D, Yoo ER, Li AA, Cholankeril G, Tighe SP, Kim W, Harrison SA, Ahmed A. Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States. Liver Int. 2019 07; 39(7):1335-1342. PMID: 30924602.
      Citations: 1     Fields:    Translation:Humans
    32. Molnar MZ, Joglekar K, Jiang Y, Cholankeril G, Abdul MKM, Kedia S, Gonzalez HC, Ahmed A, Singal A, Bhamidimarri KR, Aithal GP, Duseja A, Wong VW, Gulnare A, Puri P, Nair S, Eason JD, Satapathy SK. Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis. Liver Transpl. 2019 03; 25(3):399-410. PMID: 30369023.
      Citations: 6     Fields:    Translation:Humans
    33. Perumpail BJ, Li AA, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD. Diseases. 2019 Feb 25; 7(1). PMID: 30823570.
      Citations:    
    34. Kim D, Li AA, Perumpail BJ, Gadiparthi C, Kim W, Cholankeril G, Glenn JS, Harrison SA, Younossi ZM, Ahmed A. Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States. Hepatology. 2019 03; 69(3):1064-1074. PMID: 30014489.
      Citations: 18     Fields:    Translation:Humans
    35. Farooqui MT, Khan MA, Cholankeril G, Khan Z, Mohammed Abdul MK, Li AA, Shah N, Wu L, Haq K, Solanki S, Kim D, Ahmed A. Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2019 02; 31(2):149-156. PMID: 30234644.
      Citations: 1     Fields:    Translation:Humans
    36. Cholankeril G, Hu M, Cholankeril R, Khan MA, Gadiparthi C, Yoo ER, Perumpail RB, Nair S, Howden CW. Inpatient Outcomes for Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention. J Clin Gastroenterol. 2019 02; 53(2):120-126. PMID: 29351155.
      Citations:    Fields:    Translation:Humans
    37. Kim D, Kim W, Adejumo AC, Cholankeril G, Tighe SP, Wong RJ, Gonzalez SA, Harrison SA, Younossi ZM, Ahmed A. Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016. Hepatol Int. 2019 Mar; 13(2):205-213. PMID: 30694445.
      Citations: 3     Fields:    Translation:Humans
    38. Cholankeril G, Gadiparthi C, Yoo ER, Dennis BB, Li AA, Hu M, Wong K, Kim D, Ahmed A. Temporal Trends Associated With the Rise in Alcoholic Liver Disease-related Liver Transplantation in the United States. Transplantation. 2019 01; 103(1):131-139. PMID: 30300285.
      Citations: 2     Fields:    Translation:Humans
    39. Li AA, Cholankeril G, Berry GJ, Fernandez-Becker N. An Unexpected Colonic Mass. Am J Gastroenterol. 2019 01; 114(1):180-181. PMID: 30333533.
      Citations:    Fields:    Translation:HumansAnimals
    40. Iqbal U, Dennis BB, Li AA, Cholankeril G, Kim D, Khan MA, Ahmed A. Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis. Hepatol Int. 2019 Jan; 13(1):84-90. PMID: 30539518.
      Citations:    Fields:    Translation:Humans
    41. Kim D, Yoo ER, Li AA, Fernandes CT, Tighe SP, Cholankeril G, Hameed B, Ahmed A. Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States. Clin Gastroenterol Hepatol. 2019 10; 17(11):2379-2381. PMID: 30458247.
      Citations: 1     Fields:    
    42. Puri P, Cholankeril G, Myint TY, Goel A, Sarin SK, Harper AM, Ahmed A. Early Liver Transplantation is a Viable Treatment Option in Severe Acute Alcoholic Hepatitis. Alcohol Alcohol. 2018 Nov 01; 53(6):716-718. PMID: 30099535.
      Citations: 1     Fields:    Translation:Humans
    43. Kim D, Li AA, Perumpail RB, Cholankeril G, Gonzalez SA, Kim W, Ahmed A. Disparate Trends in Mortality of Etiology-Specific Chronic Liver Diseases Among Hispanic Subpopulations. Clin Gastroenterol Hepatol. 2019 07; 17(8):1607-1615.e2. PMID: 30391436.
      Citations: 4     Fields:    
    44. Yoo ER, Sallam S, Perumpail BJ, Iqbal U, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. When to Initiate Weight Loss Medications in the NAFLD Population. Diseases. 2018 Sep 30; 6(4). PMID: 30274326.
      Citations:    
    45. Cholankeril G, Li AA, Dennis BB, Toll AE, Kim D, Bonham CA, Nair S, Ahmed A. Increasing Trends in Transplantation of HCV-Positive Livers Into Uninfected Recipients. Clin Gastroenterol Hepatol. 2019 07; 17(8):1634-1636. PMID: 30268562.
      Citations: 1     Fields:    
    46. Perumpail BJ, Li AA, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. The Role of Vitamin E in the Treatment of NAFLD. Diseases. 2018 Sep 24; 6(4). PMID: 30249972.
      Citations:    
    47. Iqbal U, Perumpail BJ, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. Judicious Use of Lipid Lowering Agents in the Management of NAFLD. Diseases. 2018 Sep 24; 6(4). PMID: 30249980.
      Citations:    
    48. Dibba P, Li AA, Perumpail BJ, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD. Diseases. 2018 Sep 19; 6(3). PMID: 30235807.
      Citations:    
    49. Li AA, Kim D, Kim W, Dibba P, Wong K, Cholankeril G, Jacobson IM, Younossi ZM, Ahmed A. Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016. J Viral Hepat. 2018 12; 25(12):1608-1616. PMID: 30112849.
      Citations: 3     Fields:    Translation:Humans
    50. Perumpail BJ, Li AA, Iqbal U, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD. Diseases. 2018 Sep 10; 6(3). PMID: 30201879.
      Citations:    
    51. Kim D, Li AA, Gadiparthi C, Khan MA, Cholankeril G, Glenn JS, Ahmed A. Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016. Gastroenterology. 2018 10; 155(4):1154-1163.e3. PMID: 30009816.
      Citations: 20     Fields:    Translation:Humans
    52. Cholankeril G, Li AA, Cholankeril R, Toll AE, Glenn JS, Ahmed A. Impact of Drug Overdose Deaths on Solid Organ Transplantation in the United States. J Gen Intern Med. 2018 09; 33(9):1423-1425. PMID: 29766381.
      Citations: 1     Fields:    Translation:Humans
    53. Cholankeril G, Gadiparthi C, Kim D, Ahmed A. Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients. Hepatology. 2018 08; 68(2):792-793. PMID: 29672899.
      Citations:    Fields:    Translation:HumansCells
    54. Liu A, Galoosian A, Kaswala D, Li AA, Gadiparthi C, Cholankeril G, Kim D, Ahmed A. Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft. J Clin Transl Hepatol. 2018 Dec 28; 6(4):420-424. PMID: 30637220.
      Citations:    
    55. Li AA, Cholankeril G, Cheng XS, Tan JC, Kim D, Toll AE, Nair S, Ahmed A. Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era. Diseases. 2018 Jul 10; 6(3). PMID: 29996536.
      Citations:    
    56. Dibba P, Li AA, Cholankeril G, Iqbal U, Gadiparthi C, Khan MA, Kim D, Ahmed A. The Role of Cannabinoids in the Setting of Cirrhosis. Medicines (Basel). 2018 Jun 09; 5(2). PMID: 29890719.
      Citations:    
    57. Dibba P, Li A, Cholankeril G, Iqbal U, Gadiparthi C, Khan MA, Kim D, Ahmed A. Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease. Medicines (Basel). 2018 May 28; 5(2). PMID: 29843404.
      Citations:    
    58. Li AA, Dibba P, Cholankeril G, Kim D, Ahmed A. Case Report of Isoniazid-Related Acute Liver Failure Requiring Liver Transplantation. Diseases. 2018 May 19; 6(2). PMID: 29783726.
      Citations:    
    59. Gadiparthi C, Cholankeril G, Yoo ER, Hu M, Wong RJ, Ahmed A. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy. Dig Dis Sci. 2018 Jun; 63(6):1647-1653. PMID: 29611079.
      Citations:    Fields:    Translation:Humans
    60. Snyder HS, Sakaan SA, March KL, Siddique O, Cholankeril R, Cummings CD, Gadiparthi C, Satapathy SK, Ahmed A, Cholankeril G. Non-alcoholic Fatty Liver Disease: A Review of Anti-diabetic Pharmacologic Therapies. J Clin Transl Hepatol. 2018 Jun 28; 6(2):168-174. PMID: 29951362.
      Citations:    
    61. Cholankeril G, Gonzalez HC, Satapathy SK, Gonzalez SA, Hu M, Khan MA, Yoo ER, Li AA, Kim D, Nair S, Wong RJ, Kwo PY, Harrison SA, Younossi ZM, Lindor KD, Ahmed A. Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2018 06; 16(6):965-973.e2. PMID: 29427734.
      Citations: 2     Fields:    Translation:Humans
    62. Gadiparthi C, Cholankeril G, Perumpail BJ, Yoo ER, Satapathy SK, Nair S, Ahmed A. Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates. World J Gastroenterol. 2018 Jan 21; 24(3):315-322. PMID: 29391754.
      Citations: 4     Fields:    Translation:HumansCells
    63. Perumpail BJ, Khan MA, Yoo ER, Cholankeril G, Kim D, Ahmed A. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World J Gastroenterol. 2017 Dec 21; 23(47):8263-8276. PMID: 29307986.
      Citations: 48     Fields:    Translation:Humans
    64. Cholankeril G, Li AA, Yoo ER, Ahmed A. Direct-Acting Antiviral Therapy and Improvement in Graft Survival of Hepatitis C Liver Transplant Recipients. Transplantation. 2017 12; 101(12):e349. PMID: 28846556.
      Citations:    Fields:    Translation:Humans
    65. Cholankeril G, Ahmed A. Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as the Leading Indication for Liver Transplantation in the United States. Clin Gastroenterol Hepatol. 2018 08; 16(8):1356-1358. PMID: 29199144.
      Citations: 26     Fields:    Translation:Humans
    66. Perumpail BJ, Li AA, Cholankeril G, Kumari R, Ahmed A. Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis. Nutrients. 2017 Oct 13; 9(10). PMID: 29027963.
      Citations: 3     Fields:    Translation:Humans
    67. Kamal F, Khan MA, Khan Z, Cholankeril G, Hammad TA, Lee WM, Ahmed A, Waters B, Howden CW, Nair S, Satapathy SK. Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017 Oct; 29(10):1109-1117. PMID: 28763340.
      Citations: 2     Fields:    Translation:Humans
    68. Cholankeril G, Yoo ER, Perumpail RB, Liu A, Sandhu JS, Nair S, Hu M, Ahmed A. Rising Rates of Hepatocellular Carcinoma Leading to Liver Transplantation in Baby Boomer Generation with Chronic Hepatitis C, Alcohol Liver Disease, and Nonalcoholic Steatohepatitis-Related Liver Disease. Diseases. 2017 Sep 26; 5(4). PMID: 28954412.
      Citations:    
    69. Cholankeril G, Joseph-Talreja M, Perumpail BJ, Liu A, Yoo ER, Ahmed A, Goel A. Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents. J Clin Transl Hepatol. 2017 Dec 28; 5(4):363-367. PMID: 29226102.
      Citations:    
    70. Cholankeril G, Li AA, March KL, Yoo ER, Kim D, Snyder H, Gonzalez SA, Younossi ZM, Ahmed A. Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct-Acting Antiviral Agents. Clin Gastroenterol Hepatol. 2018 03; 16(3):452-453. PMID: 28838786.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    71. Cholankeril G, Yoo ER, Hu M, Gadiparthi C, Khan MA, Perumpail RB, Bonham CA, Ahmed A. Rates of liver retransplantation in the United States are declining in the era of direct-acting antiviral agents. J Viral Hepat. 2017 12; 24(12):1194-1195. PMID: 28685914.
      Citations: 1     Fields:    Translation:Humans
    72. Cholankeril G, Wong RJ, Kim D, Ahmed A. Optimal timing for hepatitis C antiviral therapy in the peritransplant period? Hepatology. 2017 09; 66(3):1004. PMID: 28586088.
      Citations:    Fields:    Translation:HumansCells
    73. Cholankeril G, Wong RJ, Hu M, Perumpail RB, Yoo ER, Puri P, Younossi ZM, Harrison SA, Ahmed A. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes. Dig Dis Sci. 2017 10; 62(10):2915-2922. PMID: 28744836.
      Citations: 29     Fields:    Translation:Humans
    74. Kamal S, Khan MA, Seth A, Cholankeril G, Gupta D, Singh U, Kamal F, Howden CW, Stave C, Nair S, Satapathy SK, Ahmed A. Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2017 Oct; 112(10):1495-1505. PMID: 28585556.
      Citations: 15     Fields:    Translation:Humans
    75. Siddique O, Joseph-Talreja M, Yoo ER, Perumpail RB, Cholankeril G, Harrison SA, Younossi ZM, Wong RJ, Ahmed A. Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States. J Clin Transl Hepatol. 2017 Sep 28; 5(3):193-196. PMID: 28936399.
      Citations:    
    76. Copelin E, Cholankeril R, Somasundar P, Cholankeril G. Portomesenteric venous thrombosis complicated by a haemorrhagic shock: a rare complication of laparoscopic gastrectomy. BMJ Case Rep. 2017 May 29; 2017. PMID: 28554887.
      Citations:    Fields:    Translation:Humans
    77. Ahmed A, Gonzalez SA, Cholankeril G, Perumpail RB, McGinnis J, Saab S, Beckerman R, Younossi ZM. Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United States. Hepatology. 2017 07; 66(1):46-56. PMID: 28257591.
      Citations: 9     Fields:    Translation:Humans
    78. Khan MA, Cholankeril G, Howden CW. Proton Pump Inhibitors and the Possible Development of Hepatic Encephalopathy in Cirrhotic Patients: True Association or Residual Confounding? Gastroenterology. 2017 06; 152(8):2076. PMID: 28478154.
      Citations: 4     Fields:    Translation:Humans
    79. Cholankeril G, Patel R, Khurana S, Satapathy SK. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management. World J Hepatol. 2017 Apr 18; 9(11):533-543. PMID: 28469809.
      Citations:    
    80. Yoo ER, Perumpail RB, Cholankeril G, Jayasekera CR, Ahmed A. The Role of e-Health in Optimizing Task-Shifting in the Delivery of Antiviral Therapy for Chronic Hepatitis C. Telemed J E Health. 2017 10; 23(10):870-873. PMID: 28375820.
      Citations: 2     Fields:    Translation:Humans
    81. Yoo ER, Perumpail RB, Cholankeril G, Jayasekera CR, Ahmed A. Expanding Treatment Access for Chronic Hepatitis C with Task-shifting in the Era of Direct-acting Antivirals. J Clin Transl Hepatol. 2017 Jun 28; 5(2):130-133. PMID: 28660150.
      Citations:    
    82. Liu A, Yoo ER, Siddique O, Perumpail RB, Cholankeril G, Ahmed A. Hepatic encephalopathy: what the multidisciplinary team can do. J Multidiscip Healthc. 2017; 10:113-119. PMID: 28392702.
      Citations:    
    83. Siddique O, Yoo ER, Perumpail RB, Perumpail BJ, Liu A, Cholankeril G, Ahmed A. The importance of a multidisciplinary approach to hepatocellular carcinoma. J Multidiscip Healthc. 2017; 10:95-100. PMID: 28360525.
      Citations:    
    84. Aggarwal A, Yoo ER, Perumpail RB, Cholankeril G, Kumari R, Daugherty TJ, Lapasaran AS, Ahmed A. Sofosbuvir Use in the Setting of End-stage Renal Disease: A Single Center Experience. J Clin Transl Hepatol. 2017 Mar 28; 5(1):23-26. PMID: 28507922.
      Citations:    
    85. Yoo ER, Perumpail RB, Cholankeril G, Ahmed A. Indications for antiviral therapy for chronic hepatitis B in pregnant mothers. BMJ Case Rep. 2016 Nov 15; 2016. PMID: 27852658.
      Citations:    Fields:    Translation:HumansCells
    86. Khan MA, Cholankeril G, Howden CW. Are proton pump inhibitors a threat for spontaneous bacterial peritonitis and hepatic encephalopathy in cirrhosis? Not so fast. Hepatology. 2017 01; 65(1):393. PMID: 27688049.
      Citations: 1     Fields:    Translation:Humans
    87. Yoo ER, Perumpail RB, Cholankeril G, Ahmed A. Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome. Case Rep Infect Dis. 2016; 2016:2605302. PMID: 27847658.
      Citations:    
    88. Perumpail RB, Yoo ER, Cholankeril G, Hogan L, Deis M, Concepcion WC, Bonham CA, Younossi ZM, Wong RJ, Ahmed A. Underutilization of Living Donor Liver Transplantation in the United States: Bias against MELD 20 and Higher. J Clin Transl Hepatol. 2016 Sep 28; 4(3):169-174. PMID: 27777886.
      Citations:    
    89. Cholankeril G, Yoo ER, Perumpail RB, Younossi ZM, Ahmed A. Disparities in Liver Transplantation Resulting From Variations in Regional Donor Supply and Multiple Listing Practices. Clin Gastroenterol Hepatol. 2017 02; 15(2):313-315. PMID: 27609705.
      Citations: 1     Fields:    Translation:Humans
    90. Cholankeril G, Perumpail RB, Pham EA, Ahmed A, Harrison SA. Nonalcoholic Fatty Liver Disease: Epidemiology, Natural History, and Diagnostic Challenges. Hepatology. 2016 09; 64(3):954. PMID: 27388553.
      Citations: 3     Fields:    Translation:Humans
    91. Yoo ER, Perumpail RB, Cholankeril G, Jayasekera CR, Ahmed A. Task-shifting - A practical strategy to improve the global access to treatment for chronic hepatitis C. Int J Nurs Stud. 2016 Oct; 62:168-9. PMID: 27497192.
      Citations: 1     Fields:    Translation:Humans
    92. Cholankeril G, Perumpail RB, Tulu Z, Jayasekera CR, Harrison SA, Hu M, Esquivel CO, Ahmed A. Trends in Liver Transplantation Multiple Listing Practices Associated With Disparities in Donor Availability: An Endless Pursuit to Implement the Final Rule. Gastroenterology. 2016 09; 151(3):382-386.e2. PMID: 27456386.
      Citations:    Fields:    Translation:Humans
    93. Cholankeril G, Hu M, Tanner E, Cholankeril R, Reha J, Somasundar P. Skilled nursing facility placement in hospitalized elderly patients with colon cancer. Eur J Surg Oncol. 2016 Nov; 42(11):1660-1666. PMID: 27387271.
      Citations: 3     Fields:    Translation:Humans
    94. Cholankeril G, Perumpail RB, Hu M, Skowron G, Younossi ZM, Ahmed A. Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C. Dig Dis Sci. 2016 09; 61(9):2505-15. PMID: 27084385.
      Citations: 2     Fields:    Translation:Humans
    95. Ahmad A, Khan H, Cholankeril G, Katz SC, Somasundar P. The impact of age on nodal metastases and survival in gastric cancer. J Surg Res. 2016 05 15; 202(2):428-35. PMID: 27229119.
      Citations: 3     Fields:    Translation:Humans
    CHOLANKERIL's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (214)
    Explore
    _
    Co-Authors (1)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _